Leibman Financial Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Leibman Financial Services's BMY Position: Q3 2026 in Review
Leibman Financial Services increased its Bristol-Myers Squibb (BMY) stake by 25% in Q3 2026, buying an estimated $1.1M and bringing the position to 86,440 shares worth $5.39M. The position accounts for 3.72% of the portfolio, ranked #6.
Leibman Financial Services first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. 1,266 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Leibman Financial Services held 86,440 shares of Bristol-Myers Squibb worth $5.39M as of Q3 2026.
- Leibman Financial Services bought 17,433 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.1M.
- Bristol-Myers Squibb made up 3.72% of Leibman Financial Services's portfolio in Q3 2026, its #6 holding.
- Leibman Financial Services first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
- 1,266 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Leibman Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.